A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. [electronic resource]
Producer: 20110617Description: 569-80 p. digitalISSN:- 1557-3265
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- antagonists & inhibitors
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Docetaxel
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- Quinolines -- administration & dosage
- Taxoids -- administration & dosage
- Uterine Cervical Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.